Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The neurofibromatoses: when less is more.

D H Gutmann1

  • 1Department of Neurology, Center for the Study of Nervous System Injury and Neurofibromatosis Program, Washington University School of Medicine, St Louis, MO 63110, USA. gutmannd@neuro.wustl.edu

Human Molecular Genetics
|March 21, 2001
PubMed
Summary

Cancer predisposition syndromes like neurofibromatosis 1 (NF1) and neurofibromatosis 2 (NF2) offer insights into tumor development. Their respective tumor suppressor genes, neurofibromin and merlin, regulate cell growth and tumor initiation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global microRNA profiling identified miR-10b-5p as a regulator of neurofibromatosis 1 (NF1)-glioma migration.

Neuropathology and applied neurobiology·2020
Same author

HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.

Molecular psychiatry·2015
Same author

The molecular and cell biology of pediatric low-grade gliomas.

Oncogene·2013
Same author

NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.

Oncogene·2013
Same author

miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells.

Oncogene·2012
Same author

Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomas.

Familial cancer·2012

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Cancer predisposition syndromes provide crucial insights into tumor pathogenesis.
  • Neurofibromatosis 1 (NF1) and neurofibromatosis 2 (NF2) are inherited cancer syndromes associated with benign and malignant tumors.
  • Mutations in NF1 and NF2 genes lead to the development of these syndromes.

Purpose of the Study:

  • To elucidate the genetic events and molecular mechanisms underlying tumor pathogenesis in NF1 and NF2.
  • To understand the distinct roles of neurofibromin (NF1) and merlin (NF2) tumor suppressor proteins in regulating cell growth and differentiation.
  • To explore how these proteins influence tumor initiation and progression.

Main Methods:

  • Review and synthesis of existing research on NF1 and NF2 genetics and biology.

Related Experiment Videos

  • Analysis of the functional mechanisms of neurofibromin and merlin proteins.
  • Investigation of signaling pathways regulated by these tumor suppressors, including p21-ras modulation.

    • Main Results:

    • Neurofibromin (NF1) inhibits cell proliferation, partly by inactivating p21-ras and modulating mitogenic signaling.
    • Merlin (NF2) functions as a membrane-associated molecular switch, regulating signals from cell surface receptors.
    • Both proteins play significant roles in the initiation and progression of tumors associated with NF1 and NF2.

    Conclusions:

    • Understanding the genetics and biology of NF1 and NF2 is key to comprehending tumor development.
    • Neurofibromin and merlin represent distinct yet critical tumor suppressors involved in cell growth regulation.
    • Further research into these pathways can inform therapeutic strategies for associated cancers.